Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant – STAT Related: FDA halts use of antibody drugs that don’t work vs. Omicron. Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
The post Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant. appeared first on Links Medicus.
Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.